Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Results of operations
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Executive or director change
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Material agreement
  10. 424B5 Offering Prospectus
  11. S-3ASR Offering Registration Statement
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 4 Option exercise Director acquired 210,000 shares (option exercise)
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. 8-K Event Other events
  20. 424B5 Offering Prospectus

Page 2 of 30 · 584 filings